You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201481 - 201490 of 207728 results
  1. USE OF MILLIMETER WAVE TECHNOLOGY IN NAVAL SHIPBORNE RADAR APPLICATIONS

    SBC: Vector Microwave Research            Topic: N/A

    POTENTIAL NAVAL SHIPBORNE MM WAVE APPLICATIONS ARE REVIEWED. EMPHASIS IS ON THE NEED TO COUNTER ANTI-SHIP MISSILE THREATS FOR WHICH PRESENT SYSTEMS MAY NOT BE EFFECTIVE, AND THE "SEA-SKIMMING" ANTI-SHIP MISSILE IS EXPECTED TO CONTINUE TO GENERATE DEMANDING SHIPBORNE FIRE CONTROL RADAR REQUIREMENTS. A COMBINATION OF VERY SHORT REACTION TIME, A SMALL RCS TARGET, AND "CLUTTER" POSES SIGNIFICANT RADAR ...

    SBIR Phase I 1987 Department of DefenseNavy
  2. Use of mimotope vaccine technology to develop vaccines against bacterial pathogens

    SBC: ZenVax LLC            Topic: NIAID

    ABSTRACT This Small Business Technology TransferSTTRPhase I proposal is in response toNIH NIAID Research Topics in Division of Microbiology and Infectious Diseases and Bacteriology and Mycology BranchVaccine for prevention of human Q feverQ fever is a worldwide zoonotic disease that is caused by the obligate intracellular Gram negative bacteriumCoxiella burnetiiThe highly infectious nature of Cbur ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  3. USE OF MODIFIED LACTOBACILLI TO BLOCK HIV TRANSMISSION

    SBC: OSEL, INC.            Topic: N/A

    Osel was founded to develop and commercialize a novel approach to prevent vaginal HIV transmission. We propose to colonize the vaginal mucosa with non-pathogenic lactobacilli, genetically modified to bind and inactivate HIV. We are constructing recombinant lactobacilli that express the potent HIV-inhibitor, cyanovirin-N (CV-N), or related HIV binding proteins. The strain of lactobacillus, L. jense ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  4. Use of Modified Lactobacilli to Block HSV Transmission

    SBC: OSEL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Genital herpes infection is extremely common throughout the world and continues to increase in incidence, Genital herpes is caused by the sexual transmission of herpes simplex virus type 2 (HSV-2), although a smaller, but increasing, percentage of cases are caused by herpes simplex virus type 1 (HSV-1) Genital herpes infection is associated with a range of clin ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  5. Use of modified TiO2 particles in psoriasis PDT therapy

    SBC: Sccd, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): According to the National Psoriasis Foundation, psoriasis is one of the leading causes of skin disease in the United States, affecting 5.5 million Americans and costing $2-$3 billion annually. An exciting, nano

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  6. USE OF MOUSE CHIMERAS TO TEST GENE FUNCTION

    SBC: MUSWORKS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This proposal is written in response to NIMH topic "F. Genetic and Transgenic Technology (subtopic 7): "Innovative technologies to study gene function and expression" listed in the 2001 Omnibus Solicitation for SBIR/STTR grants. The commercial objective of MusWorks Inc. is to provide a mouse aggregation chimera production service to the biomedical research com ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  7. Use of Mouse Chimeras to Test Gene Function

    SBC: MUSWORKS, INC.            Topic: N/A

    The commercial objective of MusWorks Inc. is to provide a mouse aggregation chimera production service to the biomedical research community. Mouse chimeras are genetically composite animals whose cells are derived from different embryos. Chimera analysis

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Use of MTR Kinase Inhibitors as Selective Herbicides and Anti-Senescence Agents

    SBC: Interlab            Topic: N/A

    The development of new herbicides continues to be an important agricultural concern in the U.S., where hundreds of millions of pounds of plant pesticides are used annually. The search for new agents that have low toxicities to non-target organisms (especially humans) requires the identification and exploitation of biochemical differences between plants and other higher eukaryotes. The enzyme methy ...

    SBIR Phase I 2002 Department of Agriculture
  9. USE OF MULTIPLE A I METHODOLOGIES TO PRODUCE A FOUNDATION FOR AN INTELLIGENT MEDICAL SYSTEM

    SBC: Intellas Group, LLC            Topic: N/A

    The practice of medicine is confounded by severe restrictions as the Human Race reaches farther out into space. A Mars mission will have communication delays of up to 40 minutes and make emergency support difficult. Intelligent medical systems will have to be devised to support these efforts. Current technologies have developed to where a combination of different artificial intelligent methodologi ...

    SBIR Phase I 2002 National Aeronautics and Space Administration
  10. Use Of Mycotrol Residue Containing B. Bassiana

    SBC: Mycotech Corporation            Topic: N/A

    Mycotech produces Mycotrol, a commercial preparation of Beauveria bassiana (Bb). The residuecontains 109 spores of Bb per gram which could be economically used to reduce European corn borer(ECB) damage to corn crops. The objective is to develop an economic bio-control strategy for ECB.Three strategies for applying the Mycotrol residue to corn are proposed:¿ inoculating the seed and/or soil duri ...

    SBIR Phase I 1997 Department of Agriculture
US Flag An Official Website of the United States Government